CorMedix Inc. (CRMD)
NASDAQ: CRMD · IEX Real-Time Price · USD
5.37
-0.15 (-2.72%)
At close: May 2, 2024, 4:00 PM
5.33
-0.04 (-0.73%)
Pre-market: May 3, 2024, 8:00 AM EDT

CorMedix Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
82
Market Cap
295.25M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20230--
Dec 31, 202265.41K-125.53K-65.74%
Dec 31, 2021190.94K-48.30K-20.19%
Dec 31, 2020239.23K-44.04K-15.55%
Dec 31, 2019283.27K-146.53K-34.09%
Dec 31, 2018429.80K100.47K30.51%
Dec 31, 2017329.33K105.22K46.95%
Dec 31, 2016224.11K13.98K6.65%
Dec 31, 2015210.13K20.86K11.02%
Dec 31, 2014189.27K187.27K9,358.97%
Dec 31, 20132.00K--
Dec 31, 20120--
Dec 31, 20110--
Dec 31, 20100--
Dec 31, 20090--
Dec 31, 20080--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Procaps Group 414.10M
Kamada 142.52M
Nektar Therapeutics 90.12M
Enanta Pharmaceuticals 73.62M
Pulmonx 68.68M
Verrica Pharmaceuticals 5.12M
XOMA Corporation 4.76M
Inovio Pharmaceuticals 832.01K
Revenue Rankings